Catherine E. Thomas

820 total citations
8 papers, 395 citations indexed

About

Catherine E. Thomas is a scholar working on Immunology, Oncology and Psychiatry and Mental health. According to data from OpenAlex, Catherine E. Thomas has authored 8 papers receiving a total of 395 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Immunology, 3 papers in Oncology and 3 papers in Psychiatry and Mental health. Recurrent topics in Catherine E. Thomas's work include Cancer, Stress, Anesthesia, and Immune Response (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). Catherine E. Thomas is often cited by papers focused on Cancer, Stress, Anesthesia, and Immune Response (3 papers), Cancer Immunotherapy and Biomarkers (3 papers) and Immunotherapy and Immune Responses (2 papers). Catherine E. Thomas collaborates with scholars based in United Kingdom and United States. Catherine E. Thomas's co-authors include W G Spilg, A. J. Cochran, R. M. MacKie, Louis J. Aronne, Alpana P. Shukla, A. Garner, I.R. Willshire, Jennifer A. Young, H. Gregory and R.M. MacKie and has published in prestigious journals such as British Journal of Cancer, British Journal of Dermatology and Obesity.

In The Last Decade

Catherine E. Thomas

8 papers receiving 339 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Catherine E. Thomas United Kingdom 7 156 119 84 70 67 8 395
Maria E. Ramirez United States 12 84 0.5× 58 0.5× 23 0.3× 100 1.4× 95 1.4× 20 592
Sharon Spence United States 8 79 0.5× 142 1.2× 51 0.6× 62 0.9× 100 1.5× 15 624
Dasheng Xu Canada 14 71 0.5× 38 0.3× 27 0.3× 128 1.8× 217 3.2× 29 518
Toshinari Kimura Japan 11 54 0.3× 108 0.9× 13 0.2× 62 0.9× 249 3.7× 36 418
Reva Schneider United States 7 86 0.6× 119 1.0× 12 0.1× 57 0.8× 135 2.0× 17 353
Grace Jordison Boxer United States 7 157 1.0× 82 0.7× 20 0.2× 63 0.9× 27 0.4× 14 461
Fred Kantrowitz United States 8 37 0.2× 54 0.5× 241 2.9× 90 1.3× 93 1.4× 13 575
Chris Fellner United States 12 73 0.5× 110 0.9× 28 0.3× 132 1.9× 51 0.8× 24 505
O Weiss Israel 9 36 0.2× 48 0.4× 12 0.1× 140 2.0× 31 0.5× 15 336
Mahmoud Kassem United States 12 76 0.5× 110 0.9× 14 0.2× 111 1.6× 46 0.7× 30 429

Countries citing papers authored by Catherine E. Thomas

Since Specialization
Citations

This map shows the geographic impact of Catherine E. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine E. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine E. Thomas more than expected).

Fields of papers citing papers by Catherine E. Thomas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine E. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine E. Thomas. The network helps show where Catherine E. Thomas may publish in the future.

Co-authorship network of co-authors of Catherine E. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine E. Thomas. A scholar is included among the top collaborators of Catherine E. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine E. Thomas. Catherine E. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Thomas, Catherine E., et al.. (2016). Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s. Obesity. 24(9). 1955–1961. 94 indexed citations
2.
Gregory, H., Catherine E. Thomas, Jennifer A. Young, I.R. Willshire, & A. Garner. (1988). The contribution of the C-terminal undecapeptide sequence of urogastrone-epidermal growth factor to its biological action. Regulatory Peptides. 22(3). 217–226. 54 indexed citations
3.
Retsas, Spyros, et al.. (1981). The effect of vindesine therapy on the in vitro immune response of patients with advanced malignant melanoma.. PubMed. 7(1). 33–7. 1 indexed citations
4.
Cochran, A. J., et al.. (1973). Cellular immunity in human malignant melanoma and melanoma histology. British Journal of Cancer. 28(1). 77–78. 40 indexed citations
5.
Cochran, Alistair J., et al.. (1973). Cellular immunity to breast carcinoma and malignant melanoma.. PubMed. 1. 77–82. 22 indexed citations
6.
Cochran, A. J., et al.. (1973). Tumor-directed cellular immunity in malignant melanoma and its modification by surgical treatment.. PubMed. 46(5). 650–4. 8 indexed citations
7.
MacKie, R. M., W G Spilg, Catherine E. Thomas, & A. J. Cochran. (1972). CELL-MEDIATED IMMUNITY IN PATIENTS WITH MALIGNANT MELANOMA. British Journal of Dermatology. 87(6). 523–528. 31 indexed citations
8.
Cochran, A. J., W G Spilg, R. M. MacKie, & Catherine E. Thomas. (1972). Postoperative Depression of Tumour-directed Cell-mediated Immunity in Patients with Malignant Disease. BMJ. 4(5832). 67–70. 145 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026